Can serum bicarbonate be used to screen for sleep disordered breathing (SDB) in obese patients?

G. Spoletini (Leeds, United Kingdom), J. Barth (Leeds, United Kingdom), D. Peckham (Leeds, United Kingdom), D. Ghosh (Leeds, United Kingdom), M. Elliott (Leeds, United Kingdom)

Source: International Congress 2018 – Obesity: comorbidities
Session: Obesity: comorbidities
Session type: Thematic Poster
Number: 2565
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Spoletini (Leeds, United Kingdom), J. Barth (Leeds, United Kingdom), D. Peckham (Leeds, United Kingdom), D. Ghosh (Leeds, United Kingdom), M. Elliott (Leeds, United Kingdom). Can serum bicarbonate be used to screen for sleep disordered breathing (SDB) in obese patients?. 2565

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nocturnal hypercapnia in eucapnic obese patients With sleep disordered breathing (SDB)
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013


Relationship between anthropometric parameters, sleep disordered breathing and airway inflammation (AI) in obese adults affected by obstructive sleep apnea (OSA)
Source: Eur Respir J 2004; 24: Suppl. 48, 118s
Year: 2004

Management of eucapnic obese patients with sleep disordered breathing (SDB)
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013


A study of prevalence of sleep disordered breathing (SDB) and obstructive sleep apnea-hypopnea syndrome (OSAHS) in treated, locoregionally controlled oral cancer
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010


Is obstructive sleep apnoea (OSA) associated with insulin resistance (IR) in severely obese adults?
Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders
Year: 2003


Sleep-disordered breathing (SDB) and obstructive sleep apnea (OSA) in elderly population with high and low BMI
Source: Annual Congress 2011 - Epidemiology, diagnosis and treatment in obstructive sleep apnoea
Year: 2011


Differences in polysomnographic (PSG) parameters between obese and non-obese patients with obstructive sleep apnea (OSA)
Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea
Year: 2019


An electronic nose distinguishes the exhaled breath of obese patients with obstructive sleep apnoea (OSA) from subjects with a similar body mass index and without OSA
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014

Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


A clinical score to predict polysomnographic (PSG) results in paediatric sleep disordered breathing (SDB)
Source: Annual Congress 2011 - Obstructive sleep apnoea : physiology, diagnostic tools and technology
Year: 2011

Normal values for sleep related respiratory variables in children and adolescents
Source: Annual Congress 2006 - Sleep apnoea in children
Year: 2006


Pulmonary function tests (PFT) and sleep disordered breathing (SDB) in morbidly obese children and adults
Source: International Congress 2016 – Latest advances in paediatric sleep medicine
Year: 2016

Effect of 8 week CPAP therapy on insulin resistance, serum leptin and lipid concentrations among obstructive sleep apnea hypopnea syndrome (OSAS) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004

Daytime sleepiness in patients on intrathecal chronic opioid (IT) therapy is not related to sleep disordered breathing (SDB)
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011

A 3-year longitudinal study of sleep disordered breathing in the elderly},
Source: Eur Respir J 2012; 40: 665-672
Year: 2012



Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients
Source: Eur Respir J 2009; 34: 694
Year: 2009



Blood pressure (BP) changes in sleep disordered breathing (SDB) of various severity
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005

The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006


Hypertension in patients with sleep disordered breathing
Source: Eur Respir J 2003; 22: Suppl. 45, 92s
Year: 2003